Antidepressant fluvoxamine shows promise as coronavirus treatment scientists say – The Washington Post

The research found that treatment with fluvoxamine (100 mg twice daily for 10 days) among high-risk outpatients with early diagnosed COVID-19 reduced the need for hospitalisation.
Just under 1,500 i… [read more]

Leave a Reply

Your email address will not be published. Required fields are marked *